Tibet Cheezheng Tibetan Medicine Co., Ltd. together with its subsidiaries, engages in the research, development, production, and sale of Tibetan medicine in China. It provides drug products in the areas of cardiovascular, respiratory, digestive, urinary and reproductive system, nervous system, musculoskeletal system, and gynecological disorders. The company was founded in 1995 and is based in Nyingchi, China. Tibet Cheezheng Tibetan Medicine Co., Ltd. operates as a subsidiary of Gansu Qizheng Industry Group Co., Ltd.

Company Data

Name Tibet Cheezheng Tibetan Medicine Co., Ltd.

Company Tibet Cheezheng Tibetan Medicine Co., Ltd.

Website https://www.cheezheng.com.cn

Primary Exchange

SHENZHEN STOCK EXCHANGE

ISIN CNE100000FM9

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Kailie Liu

Market Capitalization 16 Mrd.

Country China

Currency CNY

Employees 3,1 T

Address 2 Tibet Nyingchi Deji Road, 860000 Nyingchi

IPO Date 2009-08-28

Dividends from 'Tibet Cheezheng Tibetan Medicine Co., Ltd.'

Ex-Date	Dividend per Share
22.09.2025	0,22 CNY

Ticker Symbols

Name	Symbol
SHENZHEN STOCK EXCHANGE	002287.SZ

More Shares

Investors who hold Tibet Cheezheng Tibetan Medicine Co., Ltd. also have the following shares in their portfolio:

BERLIN, LAND LSA23/29A547 Bond

DT.BANK 16/21 SF Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog